Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Receives $12.20 Average Target Price from Analysts
Inovio Pharmaceuticals, Inc. (NASDAQ:INO – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the five analysts that are presently covering the company, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average 1-year target […]
Inovio Pharmaceuticals, Inc. (NASDAQ:INO – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the five analysts that are presently covering the company, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average 1-year target […]
